Latest filing published 12 Dec 2014 for IVAX DIAGNOSTICS INC, €8,467.
Insider track record
No signal scores available.
Gerald E. Gallwas: trading record in brief
Gerald E. Gallwas discloses dealings in Ivax Diagnostics Inc to SEC (Form 4). Altogether 4 filings, all relating to 10 December 2014.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 12 December 2014, reports an option exercise of €8,467 in Ivax Diagnostics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gerald E. Gallwas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,788 shares@ US$0.59Common Stock, par value $0.01SEC:0001437749-14-022003:0
- 25,000 shares@ US$0.55Common Stock, par value $0.01SEC:0001437749-14-022003:1
- 25,000 shares@ US$1.52Common Stock, par value $0.01SEC:0001437749-14-022003:2
- 10,000 shares@ US$1.76Common Stock, par value $0.01SEC:0001437749-14-022003:3
4 of 4 declarations